{"transactions":[{"id":1345810,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-03T21:18:08.000Z","date":"2024-11-29","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":3.87,"value":15480.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-24-036551","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924036551/rdgdoc.xml","form_type":"4"}},{"id":1412068,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-09T21:41:10.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over 2 years, with 50% cliff vesting 1-year after grant date and the remaining 50% cliff vesting 2-years after grant date."}],"balance_after":100000,"derivative":{"exercise_price":26.91,"expiration_date":"2034-09-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-028780","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924028780/rdgdoc.xml","form_type":"4"}},{"id":1505988,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T20:51:41.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over four (4) years at a rate of 1/48th each full month."}],"balance_after":10000,"derivative":{"exercise_price":22.1,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-018022","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924018022/rdgdoc.xml","form_type":"4"}},{"id":1537936,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Warrant","published_at":"2024-04-22T13:19:39.000Z","date":"2024-04-18","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":0,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-24-012643","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012643/rdgdoc.xml","form_type":"4"}},{"id":1537935,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Warrant","published_at":"2024-04-22T13:19:39.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents warrants that were originally issued on January 3, 2024 as a distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16."}],"balance_after":1000,"derivative":{"exercise_price":33,"exercise_date":"2024-01-03","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-24-012643","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012643/rdgdoc.xml","form_type":"4"}},{"id":1537934,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-04-22T13:19:39.000Z","date":"2024-04-18","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":22,"value":33000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001437749-24-012643","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924012643/rdgdoc.xml","form_type":"4"}},{"id":1765758,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T22:29:27.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over three (3) years at a rate of 1/36th each month."}],"balance_after":150000,"derivative":{"exercise_price":17.54,"expiration_date":"2033-10-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-23-027698","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000143774923027698/rdgdoc.xml","form_type":"4"}},{"id":2175228,"issuer":{"id":7294,"kind":"organization","name":"FILANA THERAPEUTICS, INC."},"owners":[{"id":85516,"kind":"person","name":"Kupiec James William","position":1,"cik":"0001839551","reported_name":"Kupiec James William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Clinical Dev. Officer"}}],"security":"Common Stock","published_at":"2022-08-24T20:02:05.000Z","date":"2022-08-23","kind":"purchase","acquired":true,"shares":2500,"price":24.44,"value":61100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase reported in column 4 is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $24.41 to $24.44 per share.  The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001069530-22-000039","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069530/000106953022000039/certent-form4.xml","form_type":"4"}}]}